Quality Sustainability in Pharma: Where Culture Becomes the True Competitive Edge
Discover how pharma leaders can build quality sustainability through resilient systems, adaptive culture and a culture of continuous improvement.
Discover how pharma leaders can build quality sustainability through resilient systems, adaptive culture and a culture of continuous improvement.

BD issues Class I correction for convenience kits containing Huons-manufactured sodium chloride ampules, flagging supplier qualification gaps for QA teams.
FDA resolves four-year albuterol shortage; Ritedose's expanded BFS capacity and four-strength portfolio now serve as standing domestic supply infrastructure.

Elicio Therapeutics secures ESMO 2026 late-breaking oral slot for Phase 2 AMPLIFY-7P data, with Phase 3 manufacturing implications for CMC teams.

ADARx prices its upsized IPO at $17.00/share, raising $535M combined with AbbVie's concurrent 4.9% private placement stake.
Latest edition
SPONSORED
SPONSORED
SPONSORED

Sep 28
Oct 06
Oct 20From native content to event partnerships, we help brands earn the attention of a hard-to-reach, senior audience — without breaking the reading experience.
See partnership options →Explore expert-led guides crafted for pharma professionals. Log in to download and stay ahead.








Join thousands of pharma professionals getting our sharpest reporting, briefings and guides — free.
